ITeos Therapeutics Newsroom

ITeos Therapeutics Reports Q1 2025 Financial Results

TipRanksApr 30 00:48 ET

Wells Fargo Maintains ITeos Therapeutics(ITOS.US) With Buy Rating, Cuts Target Price to $16

Moomoo NewsApr 29 13:32 ET · Ratings

Piper Sandler Maintains ITeos Therapeutics(ITOS.US) With Buy Rating, Maintains Target Price $16

Moomoo NewsApr 29 13:32 ET · Ratings

H.C. Wainwright Maintains ITeos Therapeutics(ITOS.US) With Buy Rating, Maintains Target Price $21

Moomoo NewsApr 29 13:32 ET · Ratings

Wells Fargo Maintains Overweight on ITeos Therapeutics, Lowers Price Target to $16

BenzingaApr 29 10:03 ET · Ratings

ITeos Therapeutics Analyst Ratings

BenzingaApr 29 10:02 ET · Ratings

ITeos Therapeutics | 10-Q: Q1 2025 Earnings Report

SECApr 28 16:37 ET · Announcements

ITeos Therapeutics 1Q Loss $34.6M >ITOS

Dow JonesApr 28 16:35 ET

Express News | ITeos Therapeutics Q1 EPS $(0.80) Beats $(0.95) Estimate

BenzingaApr 28 16:34 ET

ITeos Therapeutics: Cash, Investment Balance of $624.3 M as of March 31 Expected to Provide Runway Through 2027 >ITOS

Dow JonesApr 28 16:31 ET

Express News | Iteos Reports First Quarter 2025 Financial Results and Provides Business Updates

ReutersApr 28 16:30 ET

ITeos Reports First Quarter 2025 Financial Results and Provides Business Updates

GlobeNewswireApr 28 16:30 ET

Positive Week for ITeos Therapeutics, Inc. (NASDAQ:ITOS) Institutional Investors Who Lost 38% Over the Past Year

Yahoo FinanceApr 19 08:31 ET

Companies Like ITeos Therapeutics (NASDAQ:ITOS) Are In A Position To Invest In Growth

Simply Wall StApr 18 07:24 ET

$ITOS Stock Is up 7% Today. Here's What We See in Our Data.

Quiver QuantitativeApr 15 11:31 ET

12 Health Care Stocks Moving In Thursday's Pre-Market Session

BenzingaApr 3 08:05 ET

BeiGene Slips on Decision to Halt Lung Cancer Program

Seeking AlphaApr 3 06:58 ET

Piper Sandler Initiates ITeos Therapeutics(ITOS.US) With Buy Rating, Announces Target Price $16

Moomoo NewsMar 31 13:31 ET · Ratings

ITeos Therapeutics (ITOS) Gets a Buy From Piper Sandler

TipRanksMar 31 06:56 ET · Ratings

ITeos To Present Preclinical Data On Potential Best-In-Class Anti-TREM2 Antibody, EOS-215, And Novel PTPN1/2 Inhibitor At The AACR Annual Meeting 2025

BenzingaMar 25 16:35 ET